Neuroendokrin daganatok: vizsgálatok itt: Egyesült Államok
89 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Where
- Charlottesville, Columbus, Iowa City, Jacksonville, Lexington, Los Angeles, Nashville, Phoenix, Portland, Rochester, Salt Lake City, St Louis
- Életkor
- 18 év and over
- People
- 104 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT07165132 - 2. fázisTaking peopleAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Where
- Bethesda
- Életkor
- 18 év to 72 év
- People
- 285
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03412877 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Albuquerque, Bethesda, Beverly Hills, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Cleveland, Columbus, Dallas, Detroit, Durham, Fairfax, Fargo, Grand Rapids, Jacksonville, Knoxville, Lexington, Los Angeles, Metairie, Milwaukee, Nashville, New York, Omaha, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, Santa Monica, Seattle, St Louis, Tampa, Tucson, Vallejo, Washington D.C.
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 1. fázisTaking peoplePilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
- Where
- Boston
- Életkor
- 18 év and over
- People
- 30
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06062745 - 2. fázisTaking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - 1. fázisTaking peopleAutologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07509034 - 3. fázisCsak meghívásosLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Where
- Bay Shore, Houston, Kettering, Memphis
- People
- 5000
- Run by
- Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00 - No phaseTaking peopleA Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
- Where
- Sacramento
- Életkor
- 18 év and over
- People
- 9
- Run by
- University of California, Davis
See details and how to joinNCT05160480 - 2. fázisTaking peopleLu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- Where
- Bethesda
- Életkor
- 18 év to 100 év
- People
- 130
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03206060 - 1/2. fázisTaking peopleStudy of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Where
- Atlanta, Chicago, Cleveland, Glen Burnie, Houston, Omaha, Princeton, Tampa
- Életkor
- 18 év and over
- People
- 138
- Run by
- Molecular Partners AG
See details and how to joinNCT07278479 - 1. fázisTaking peopleTesting the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Where
- City of Saint Peters, Creve Coeur, Duarte, Irvine, Orange, Shiloh, St Louis
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05687123 - 2. fázisNot yet taking people in Egyesült ÁllamokTemozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
- Where
- Buffalo
- Életkor
- 18 év and over
- People
- 60
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06202066 - No phaseTaking peopleTissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 2000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02146170 - 2. fázisTaking peopleNatural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- Where
- Bethesda
- Életkor
- 12 év and over
- People
- 740
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04074135 - 1/2. fázisTaking peopleLu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
- Where
- Bethesda
- Életkor
- 18 év to 100 év
- People
- 56
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04086485 - 1/2. fázisTaking peopleSomatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 66
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06427798 - 1. fázisTaking peopleA First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Where
- Dallas, Hackensack, Houston, Nashville, New York, Seattle, St Louis
- Életkor
- 18 év and over
- People
- 110
- Run by
- Moonlight Bio, Inc
See details and how to joinNCT07488923 - No phaseTaking peopleA Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
- Where
- East Hanover
- Életkor
- 18 év to 110 év
- People
- 4023
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07635316 - 2. fázisTaking peopleZanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
- Where
- Rochester, St Louis
- Életkor
- 18 év and over
- People
- 32
- Run by
- Washington University School of Medicine
See details and how to joinNCT06926634 - 1/2. fázisTaking peopleTargeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Where
- Baltimore, Chapel Hill, Chicago, Cleveland, Columbus, Detroit, Fairfax, Grand Rapids, Iowa City, Jacksonville, Lexington, Miami, Milwaukee, Nashville, Omaha, Orlando, Rochester, Seattle, St Louis, Troy
- Életkor
- 18 év to 90 év
- People
- 300
- Run by
- Perspective Therapeutics
See details and how to joinNCT05636618 - No phaseCsak meghívásosEndoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 12
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07619417 - 2. fázisTaking peopleCapTemY90 for Grade 2/3 NET Liver Metastases
- Where
- Buffalo, La Jolla, Miami, Philadelphia
- Életkor
- 18 év and over
- People
- 70
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT04339036 - 1. fázisNot yet taking people in Egyesült Államok211At-MABG in Adults With Advanced Neuroendocrine Cancers
- Where
- Philadelphia
- Életkor
- 18 év and over
- People
- 16
- Run by
- University of Pennsylvania
See details and how to joinNCT07661420 - 1. fázisTaking people[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06479811 - 1/2. fázisTaking peopleRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Where
- Gilbert, Seattle, Tucson
- Életkor
- 18 év to 99 év
- People
- 30
- Run by
- University of Arizona
See details and how to joinNCT06814496